EUVIMEDEUVIMED entdecken
Crossref

Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization

Luca Famlonga, Lorenzo Chiaverini, Jana Timotijević, Ana Kandić, Stefan R Nikolić, Antoine Dupé, Simona M Sigona, Elisabetta Barresi, Chiara Giacomelli, Ljiljana E Mihajlović, Tiziano Marzo iD, Jelena Poljarević

JBIC Journal of Biological Inorganic Chemistry · 2026

DOI: 10.1007/s00775-026-02174-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JBIC Journal of Biological Inorganic Chemistry, 2026. Verfasst von Luca Famlonga und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, Pisa, 56126, Italy. Hauptthemen laut MEDLINE: Flavonoids, Rhenium, Antineoplastic Agents, Coordination Complexes. Die Arbeit nennt 55 Literaturangaben. Gefördert von: European Research Executive Agency, Ministry of Science, Technological Development and Innovation of Republic of Serbia, Università di Pisa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chrysin, structurally one of the simplest flavonoids, shows a broad spectrum of biological activities, particularly its anticancer potential. Additionally, it has the possibility of coordination to metal ions as a bidentate chelate ligand, forming highly stable metal complexes. This synergism of metal ions and Chrysin led to a significant improvement in its diverse biological activities. Chrysin (HL1) and its derivatives (methoxy (HL2), benzyloxy (HL3), acetylated (HL4), and silylated (HL5)) were coordinated as OO-bidentate ligands to the rhenium(V) ion, and all five complexes crystallized in the form of monocrystals. The stability studies in PBS and human blood plasma solution were performed for those compounds, indicating that all complexes underwent precipitation in PBS, whereas no precipitation was observed in plasma. Moreover, the spectral profiles recorded in plasma indicate that plasma components exert a significant stabilizing effect on the rhenium complexes. The antiproliferative activity of complexes 1-5 was evaluated against the human ovarian carcinoma (A2780), colorectal carcinoma (HCT116), and the non-malignant HEK293 cell line. No direct relationship could be established between the complex precipitation in plasma and its cytotoxic activity. Complex 3 displayed pronounced spectral modifications in plasma while remaining essentially inactive in all cell lines tested, whereas 1 exhibited comparatively limited spectral changes despite being among the most active compounds of the series. The most active complexes 5, 1, and 2 displayed significant selectivity, with lower cytotoxicity toward non-tumorigenic HEK293 cells than A2780 and HCT116 cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsRheniumAntineoplastic AgentsCoordination ComplexesHumansLigandsCell ProliferationCell Line, TumorDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

Anticancer metallodrugsChrysinFlavonoidPlasma studiesRhenium

Substanzen

FlavonoidschrysinRheniumLigandsAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, Pisa, 56126, Italy.
  • University of Belgrade - Faculty of Chemistry, Studentski trg 12-16, Belgrade, 11158, Serbia.
  • Innovation Center of the Faculty of Chemistry, Studentski trg 12-16, Belgrade, 11158, Serbia.
  • Institute of Chemistry, University of Graz, Schuberstr. 1, Graz, 8010, Austria.
  • Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, Pisa, 56126, Italy. tiziano.marzo@unipi.it.
  • University of Belgrade - Faculty of Chemistry, Studentski trg 12-16, Belgrade, 11158, Serbia. jelenal@chem.bg.ac.rs.

ORCID-Profile: Tiziano Marzo

Förderung

  • European Research Executive Agency
  • Ministry of Science, Technological Development and Innovation of Republic of Serbia
  • Università di Pisa
  • NAWI Graz

Zitieren

APA

Famlonga, L., Chiaverini, L., Timotijević, J., Kandić, A., Nikolić, S. R., Dupé, A., Sigona, S. M., Barresi, E., Giacomelli, C., Mihajlović, L. E., Marzo, T., & Poljarević, J. (2026). Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization. JBIC Journal of Biological Inorganic Chemistry. https://doi.org/10.1007/s00775-026-02174-9

Vancouver

Famlonga L, Chiaverini L, Timotijević J, Kandić A, Nikolić SR, Dupé A, et al. Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization. JBIC Journal of Biological Inorganic Chemistry. 2026. doi:10.1007/s00775-026-02174-9

BibTeX
@article{Famlonga2026,
  author = {Famlonga, Luca and Chiaverini, Lorenzo and Timotijević, Jana and Kandić, Ana and Nikolić, Stefan R and Dupé, Antoine and Sigona, Simona M and Barresi, Elisabetta and Giacomelli, Chiara and Mihajlović, Ljiljana E and Marzo, Tiziano and Poljarević, Jelena},
  title = {Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization},
  journal = {JBIC Journal of Biological Inorganic Chemistry},
  year = {2026},
  doi = {10.1007/s00775-026-02174-9}
}
Kostenlos starten →